Cargando…

A single arm phase Ib/II trial of first-line pembrolizumab, trastuzumab and chemotherapy for advanced HER2-positive gastric cancer

In this multi-center phase II trial, we evaluated the efficacy and safety of a quadruplet regimen (pembrolizumab, trastuzumab, and doublet chemotherapy) as first-line therapy for unresectable or metastatic human epidermal growth factor receptor 2 (HER2)-positive advanced gastric cancer (AGC) (NCT029...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Choong-kun, Rha, Sun Young, Kim, Hyo Song, Jung, Minkyu, Kang, Beodeul, Che, Jingmin, Kwon, Woo Sun, Park, Sejung, Bae, Woo Kyun, Koo, Dong-Hoe, Shin, Su-Jin, Kim, Hyunki, Jeung, Hei-Cheul, Zang, Dae Young, Lee, Sang Kil, Nam, Chung Mo, Chung, Hyun Cheol
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556512/ https://www.ncbi.nlm.nih.gov/pubmed/36224176 http://dx.doi.org/10.1038/s41467-022-33267-z

Ejemplares similares

Probe-Based Confocal Laser Endomicroscopy versus White-Light Endoscopy with Narrow-Band Imaging for Predicting and Collecting Residual Cancer Tissue in Patients with Gastric Cancer Receiving Chemotherapy
por: Kim, Yuna, et al.
Publicado: (2022)

Depth of response is a significant predictor for long-term outcome in advanced gastric cancer patients treated with trastuzumab
por: Lee, Choong-Kun, et al.
Publicado: (2017)

Prediction of metachronous multiple primary cancers following the curative resection of gastric cancer
por: Kim, Chan, et al.
Publicado: (2013)

The UGT1A9*22 genotype identifies a high-risk group for irinotecan toxicity among gastric cancer patients
por: Lee, Choong-kun, et al.
Publicado: (2022)

Prior antibiotic administration disrupts anti-PD-1 responses in advanced gastric cancer by altering the gut microbiome and systemic immune response
por: Kim, Chang Gon, et al.
Publicado: (2023)

Benefits of Recurrent Colonic Stent Insertion in a Patient with Advanced Gastric Cancer with Carcinomatosis Causing Colonic Obstruction
por: Park, Semi, et al.
Publicado: (2009)

Genome-wide genetic aberrations of thymoma using cDNA microarray based comparative genomic hybridization
por: Lee, Gui Youn, et al.
Publicado: (2007)

Improving the prediction accuracy in classification using the combined data sets by ranks of gene expressions
por: Kim, Ki-Yeol, et al.
Publicado: (2008)

Differential Prognostic Implications of Gastric Signet Ring Cell Carcinoma: Stage Adjusted Analysis From a Single High-volume Center in Asia
por: Chon, Hong Jae, et al.
Publicado: (2017)

Cardiotoxicity of trastuzumab in patients with HER2-positive gastric cancer
por: Soo Park, Ji, et al.
Publicado: (2017)

Mechanism of enhancement of radiation-induced cytotoxicity by sorafenib in colorectal cancer
por: Kim, Yong Bae, et al.
Publicado: (2013)

Overexpression of Class III Beta Tubulin and Amplified HER2 Gene Predict Good Response to Paclitaxel and Trastuzumab Therapy
por: Jung, Minkyu, et al.
Publicado: (2012)

Phase Ib study of pembrolizumab in combination with trastuzumab emtansine for metastatic HER2-positive breast cancer
por: Waks, Adrienne G, et al.
Publicado: (2022)

PTEN loss and level of HER2 amplification is associated with trastuzumab resistance and prognosis in HER2-positive gastric cancer
por: Kim, Chan, et al.
Publicado: (2017)

S-1 Monotherapy as a Neoadjuvant Treatment for Locally Advanced Gastric Cancer
por: Jung, Jong Yul, et al.
Publicado: (2008)

Novel and simple transformation algorithm for combining microarray data sets
por: Kim, Ki-Yeol, et al.
Publicado: (2007)

Monitoring the Outcomes of Systemic Chemotherapy Including Immune Checkpoint Inhibitor for HER2-Positive Metastatic Gastric Cancer by Liquid Biopsy
por: Jung, Seung-Hyun, et al.
Publicado: (2023)

Detection of asymptomatic recurrence improves survival of gastric cancer patients
por: Park, Ji Soo, et al.
Publicado: (2021)

Comprehensive immune profiling and immune-monitoring using body fluid of patients with metastatic gastric cancer
por: Park, Hyung Soon, et al.
Publicado: (2019)

Psoriasis Induced by Trastuzumab (Herceptin®)
por: Kim, Dae Hun, et al.
Publicado: (2013)

Temsirolimus in Asian Metastatic/Recurrent Non-clear Cell Renal Carcinoma
por: Lee, Jii Bum, et al.
Publicado: (2019)

Identification of a radiosensitivity signature using integrative metaanalysis of published microarray data for NCI-60 cancer cells
por: Kim, Han Sang, et al.
Publicado: (2012)

Two Dosages of Oral Fluoropyrimidine S-1 of 35 and 40 mg/m(2) bid: Comparison of the Pharmacokinetic Profiles in Korean Patients with Advanced Gastric Cancer
por: Jeung, Hei-Cheul, et al.
Publicado: (2010)

Multidisciplinary treatment for patients with stage IV gastric cancer: the role of conversion surgery following chemotherapy
por: Beom, Seung-Hoon, et al.
Publicado: (2018)

Salvage chemotherapy of biweekly irinotecan plus S-1 (biweekly IRIS) in previously treated patients with advanced gastric cancer
por: Chon, Hong Jae, et al.
Publicado: (2011)

Transcriptome analysis of iBET-151, a BET inhibitor alone and in combination with paclitaxel in gastric cancer cells
por: Kang, Sun Kyoung, et al.
Publicado: (2020)

Comprehensive expression profiles of gastric cancer molecular subtypes by immunohistochemistry: implications for individualized therapy
por: Kim, Hyo Song, et al.
Publicado: (2016)

High Serum Levels of IL-6 Predict Poor Responses in Patients Treated with Pembrolizumab plus Axitinib for Advanced Renal Cell Carcinoma
por: Sang, Yun Beom, et al.
Publicado: (2022)

Immunohistochemistry Biomarkers Predict Survival in Stage II/III Gastric Cancer Patients: From a Prospective Clinical Trial
por: Kim, Min Hwan, et al.
Publicado: (2019)

Receptor tyrosine kinase amplified gastric cancer: Clinicopathologic characteristics and proposed screening algorithm
por: Park, Cheol Keun, et al.
Publicado: (2016)

Significance of Metabolic Tumor Volume and Total Lesion Glycolysis Measured Using (18)F-FDG PET/CT in Locally Advanced and Metastatic Gallbladder Carcinoma
por: Chun, You Jin, et al.
Publicado: (2019)

Application of Efficient Data Cleaning Using Text Clustering for Semistructured Medical Reports to Large-Scale Stool Examination Reports: Methodology Study
por: Woo, Hyunki, et al.
Publicado: (2019)

Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma
por: Finn, Richard S., et al.
Publicado: (2020)

Complementary utility of targeted next-generation sequencing and immunohistochemistry panels as a screening platform to select targeted therapy for advanced gastric cancer
por: Kim, Hyo Song, et al.
Publicado: (2017)

Real-World Clinical Outcomes of Biosimilar Trastuzumab (CT-P6) in HER2-Positive Early-Stage and Metastatic Breast Cancer
por: Bae, Soong June, et al.
Publicado: (2021)

Trastuzumab Specific Epitope Evaluation as a Predictive and Prognostic Biomarker in Gastric Cancer Patients
por: Koh, Jiwon, et al.
Publicado: (2019)

S-1 Based Doublet as an Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer: Results from the Randomized Phase III POST Trial
por: Lee, Choong-kun, et al.
Publicado: (2019)

PTEN Methylation Dependent Sinonasal Mucosal Melanoma
por: Lee, Sang Hee, et al.
Publicado: (2016)

Application of the Western-based adjuvant online model to Korean colon cancer patients; a single institution experience
por: Jung, Minkyu, et al.
Publicado: (2012)

Outcomes of an Acute Palliative Care Unit at a Comprehensive Cancer Center in Korea
por: Lee, Si Won, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_201rsuoc16u8padd141gakc8b4